Amyloid beta-Protein (Human, 1 – 28)

Amyloid β-Protein (Human, 1 – 28) | SP-28 (Human)

4481-v 0.5 mg | 120.00 EUR

Synthetic Product (Trifluoroacetate Form)

Asp – Ala – Glu – Phe – Arg – His – Asp – Ser – Gly – Tyr – Glu – Val – His – His – Gln – Lys – Leu – Val – Phe – Phe – Ala – Glu – Asp – Val – Gly – Ser – Asn – Lys

The purity is guaranteed to be higher than 99.0% by HPLC

Amyloidogenic Segment of Amyloid β-Protein

References:

1. D.A. Kirschner, H. Inouye, L.K. Duffy, A. Sinclair, M. Lind and D.J. Selkoe, Proc. Natl. Acad. Sci. U.S.A., 84, 6953 (1987) (Original; Amyloid-Like Fibril Formation)
2. B. Klajnert, M. Cortijo-Arellano, J. Cladera, and M. Bryszewska, Biochem. Biophys. Res. Commun., 345, 21 (2006) (Amyloid Fibril Formation)
3. A. Perálvarez-Marin, A. Barth and A. Gräslund, J. Mol. Biol., 379, 589 (2008) (Amyloid Fibril Formation)
4. N.G.N. Milton and J.R. Harris, Micron, 40, 800 (2009) (Amyloid Fibril Formation)
5. T. Wasiak, M. Ionov, K. Nieznanski, H. Nieznanska, O. Klementieva, M. Granell, J. Cladera, J.-P. Majoral, A.M. Caminade and B. Klajnert, Mol. Pharm., 9, 458 (2012) (Amyloid Fibril Formation and Neurotoxicity)
6. J.S. Whitson, D.J. Selkoe and C.W. Cotman, Science, 243, 1488 (1989) (Pharmacol)
7. B.A. Yankner, L.K. Duffy, and D.A. Kirschner, Science 250, 279 (1990) (Pharmacol)